GGenetics Read More Expands Genetic Hearing Loss Pipeline with $1.3B RNA Therapy Partnership19 May 2025 On May 16, Eli Lilly and Company (NYSE:LLY) announced a partnership with Rznomics to develop RNA-based gene therapies…